Compound

Active

Overview

Compound is a thesis-driven, research-centric venture capital firm based in New York that invests in 'n-of-1' opportunities in AI/ML, robotics, biotech, crypto, deeptech, enterprise, and Web3. It focuses on underappreciated science projects and bleeding-edge technologies built by outliers, with check sizes ranging from $100K to $3M in pre-seed, seed, and Series A rounds primarily in the USA and Europe. The firm manages a $73M fund and emphasizes underwriting technical and scientific risk while supporting founders in team, product, commercialization, and narrative.

History

Compound was founded around 2009 as a venture capital firm specializing in thesis-driven investments. It has raised a $73M fund, with investments made in 2023 and continuing into 2024 across AI, biotech, and other deep tech sectors. Key milestones include deploying capital into underappreciated 'n-of-1' projects and publishing annual letters detailing investment activity and thesis evolution.

Reputation

Compound is perceived by professionals as a specialized VC firm effective at identifying niche, high-risk technical investments overlooked by larger funds, with strengths in creative thinking and scientific risk assessment. Enthusiasts in AI and deeptech communities value its research-centric approach and support for outlier founders. Criticisms are limited in available sources, though its small team size may constrain deal flow compared to larger VCs.

Sources (4)